Author:
Ahmet Djevdet S.,Basheer Haneen A.,Salem Anwar,Lu Di,Aghamohammadi Amin,Weyerhäuser Patrick,Bordiga Andrea,Almeniawi Juman,Rashid Sabah,Cooper Patricia A.,Shnyder Steven D.,Vinader Victoria,Afarinkia Kamyar
Abstract
AbstractThe formylpeptide receptor-1 (FPR1) is a member of the chemotactic GPCR-7TM formyl peptide receptor family, whose principle function is in trafficking of various leukocytes into sites of bacterial infection and inflammation. More recently, FPR1 has been shown to be expressed in different types of cancer and in this context, plays a significant role in their expansion, resistance and recurrence. ICT12035 is a selective and potent (30 nM in calcium mobilisation assay) small molecule FPR1 antagonist. Here, we demonstrate the efficacy of ICT12035, in a number of 2D and 3D proliferation and invasion in vitro assays and an in vivo model. Our results demonstrate that targeting FPR1 by a selective small molecule antagonist, such as ICT12035, can provide a new avenue for the treatment of cancers.
Funder
Yorkshire Cancer Research
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Le, Y., Sun, R., Ying, G., Iribarren, P. & Wang, J. The role of formyl peptide receptors in microbial infection and inflammation. Curr. Med. Chem. 2, 83–93 (2003).
2. Le, Y., Murphy, P. M. & Wang, J. M. Formyl-peptide receptors revisited. Trends Immunol. 23, 541–548 (2002).
3. Le, Y., Oppenheim, J. J. & Wang, J. M. Pleiotropic roles of formyl peptide receptors. Cytokine Growth Factor Rev. 12, 91–105 (2001).
4. Yang, D. et al. Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation. J. Leukoc. Biol. 72, 598–607 (2002).
5. Kim, S. D. et al. Functional expression of formyl peptide receptor family in human NK cells. J. Immunol. 183, 5511–5517 (2009).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献